Translational Oncology: Volume 13 (Issue 1 to Issue 12)
Title: Translational Oncology: Bridging Research for Improved Cancer Care
Introduction: Translational Oncology is a prestigious journal that serves as a vital link between laboratory research and clinical practice in the field of oncology. By publishing novel research investigations, the journal aims to bridge the gap between basic science discoveries and their practical application in the diagnosis, treatment, and prevention of human cancers. Translational Oncology focuses on risk assessment, cellular and molecular characterization, and innovative therapeutic interventions, with the ultimate goal of enhancing the clinical care of oncology patients.
Scope: The journal covers a broad range of topics that facilitate the translation of cutting-edge research into clinical practice. Researchers contribute original reports that provide insights into the cellular and molecular mechanisms underlying cancer development and progression. These studies contribute to risk assessment, identifying potential biomarkers, and characterizing novel therapeutic targets.
Laboratory Studies and Clinical Trials: Translational Oncology welcomes laboratory studies exploring innovative therapeutic interventions, including the development and preclinical evaluation of new drugs, immunotherapies, and targeted therapies. By showcasing promising laboratory findings, the journal facilitates the translation of these discoveries into clinical applications that may benefit cancer patients.
Moreover, Translational Oncology features clinical trials that evaluate new treatment paradigms for cancer patients. These studies assess the safety and efficacy of novel therapies and treatment regimens, providing critical evidence to inform clinical decision-making and improve patient outcomes.
Peer-Reviewed Manuscript Types: The journal encompasses three primary manuscript types. Original reports present novel research findings that span the laboratory and clinical settings, advancing our understanding of cancer biology and therapeutic approaches. Reviews provide comprehensive and critical evaluations of current research trends, enabling readers to grasp the latest advances in oncology. Editorials offer expert insights, commentary, and perspectives on significant developments in translational research, fostering dialogue and knowledge exchange within the oncology community.
Conclusion: Translational Oncology stands at the forefront of oncology research, facilitating the translation of laboratory discoveries into clinical applications for the benefit of cancer patients worldwide. By providing a platform for original reports, reviews, and editorials, the journal fosters collaboration between laboratory and clinical scientists, accelerating the progress towards improved cancer care. Through its dedication to bridging the gap between basic science and clinical practice, Translational Oncology plays a pivotal role in advancing the field of oncology and bringing us closer to the ultimate goal of conquering cancer.
Volume 13, Issue 1: Pages 1-124 (January 2020)
Volume 13, Issue 2: Pages 125-492 (February 2020)
Volume 13, Issue 3: March 2020
Volume 13, Issue 4: April 2020
Volume 13, Issue 5: May 2020
Volume 13, Issue 6: June 2020
Volume 13, Issue 7: July 2020
Volume 13, Issue 8: August 2020
Volume 13, Issue 9: September 2020
Volume 13, Issue 10: October 2020
Volume 13, Issue 11: November 2020
Volume 13, Issue 12: December 2020
Reviews
There are no reviews yet.